ArticleBMC cancer2017

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.